Blog

MSC Therapy for Burn Wounds and Chronic Skin Regeneration: 2026 Breakthroughs in Exosome-Based Healing

New 2026 research reveals UC-MSC exosomes combined with low-intensity pulsed ultrasound and curcumin-hydrogel systems achieve remarkable burn wound healing — including MRSA-infected wounds — through autophagy regulation,…

Aug 14, 2026

Stem Cells and Alzheimer’s Disease: A Patient’s Guide to What 2026 Research Shows

2026 patient guide to MSC therapy for Alzheimer’s disease: how it differs from lecanemab and donanemab, who is a candidate, what outcomes to expect, the 6 active clinical trials including NCT06775964 and the first MSC + …

Aug 13, 2026

Is Stem Cell Therapy Legal and Safe in Thailand? (2026 Patient Guide)

Is Stem Cell Therapy Legal and Safe in Thailand? For international patients considering regenerative treatments, traveling abroad for stem cell therapy brings both immense hope and important practical questions. As medic…

Aug 13, 2026

The First FDA-Approved Stem Cell Therapy for Type 1 Diabetes: What Zimislecel Means for Patients in 2026

Zimislecel (VX-880) is the first stem cell-derived islet therapy to reach the FDA, and the September 2025 NEJM paper showed 12 of 12 patients achieving insulin independence. Here’s what it means for T1D patients in 2026,…

Aug 13, 2026

MSC Exosome and Stem Cell Therapy for Psoriasis: 2026 Mechanism, Trials, and Clinical Landscape

5 MSC and exosome trials for psoriasis have reported completion; three 2026 mechanistic studies reveal novel Ang1/Tie2 angiogenesis mechanisms, engineered exosome-nanoparticle platforms, and culture medium optimization f…

Aug 13, 2026

MSC Therapy for Degenerative Disc Disease: A 2026 Meta-Analysis of Randomized Trials and the Cell-Free Exosome Frontier

A 2026 meta-analysis of 7 randomized trials confirms intradiscal MSC injections reduce chronic back pain and disability significantly. Meanwhile, bioengineered exosome therapies are redefining what cell-free disc regener…

Aug 12, 2026

MSC Therapy for Peripheral Arterial Disease and Critical Limb Ischemia: 2026 Clinical and Mechanistic Breakthroughs

CRISPR-edited MSCs, iPSC-derived cells, combinatorial cell therapy, and exosome-based approaches are transforming PAD/CLI treatment. Six landmark 2026 papers and five active clinical trials reviewed for clinicians and re…

Aug 12, 2026

MSC Therapy for Pulmonary Arterial Hypertension: Mechanisms, Mitochondrial Repair.

Pulmonary arterial hypertension kills half its patients within five years. 2026 research shows mesenchymal stem cells — especially HO-1-modified and mitochondria-primed MSCs — are reversing the vascular remodeling at the…

Aug 12, 2026

Can Stem Cell Exosomes Restore Hearing? What the 2026 Breakthrough Means for You

A 2026 Phase 1 trial showed that MSC-derived exosomes injected into the ear were safe and improved hearing in patients with sudden sensorineural hearing loss. Here’s what the breakthrough means and when it could be avail…

Aug 12, 2026

How Much Does Stem Cell Therapy Cost in 2026? A Patient’s Realistic Guide

Stem cell therapy prices range from $2,000 to $100,000 depending on where you go. Here’s what actually drives the cost, what’s included, and how Thailand compares to the US, Australia, and Europe in 2026.

Jun 25, 2026

MSC Therapy for Inflammatory Bowel Disease: Crohn’s and Ulcerative Colitis in 2026

MSC therapy is offering new hope for IBD patients who don’t respond to conventional biologics. Here’s what the 2026 clinical data shows.

Jun 24, 2026

MSC Extracellular Vesicles for Skin Photoaging: Kaempferol-Modified EVs and ADAM10 Suppression

Kaempferol-modified MSC extracellular vesicles suppress ADAM10 and restore UV-damaged collagen. This is the future of anti-aging skin repair.

Jun 23, 2026

Page 3 of 13 — 156 posts